Codeprex FDA Approval History
FDA Approved: Yes (Discontinued) (First approved June 21, 2004)
Brand name: Codeprex
Generic name: chlorpheniramine polistirex and codeine polistirex
Dosage form: Extended Release Suspension
Company: Lannett Company, Inc.
Treatment for: Cough
Marketing Status: Discontinued
Codeprex (chlorpheniramine polistirex and codeine polistirex) is an antihistamine and cough suppressant combination for the treatment of cough.
Development Timeline for Codeprex
|Jun 21, 2004||Codeprex Celltech Group plc - Treatment for Cough|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.